227 related articles for article (PubMed ID: 34131795)
1. Clinical efficacy of adipocyte-derived stem cells conditioned media combined with micro-injury in refractory patch of alopecia areata.
Lee SB; Shin HT; Byun JW; Shin J; Choi GS
Arch Dermatol Res; 2022 Aug; 314(6):527-532. PubMed ID: 34131795
[TBL] [Abstract][Full Text] [Related]
2. Comparative study between topical application of triamcinolone acetonide after fractional carbon dioxide laser versus microneedling in the treatment of resistant alopecia areata.
Omar MM; Obaid ZM; Sayedahmed OME
Dermatol Ther; 2022 Dec; 35(12):e15913. PubMed ID: 36209381
[TBL] [Abstract][Full Text] [Related]
3. Fractional CO
Abd ElKawy FAE; Aly SHM; Ibrahim SMA
Dermatol Ther; 2022 Jul; 35(7):e15553. PubMed ID: 35509110
[TBL] [Abstract][Full Text] [Related]
4. Fractional Laser-assisted Hair Regrowth and Microneedling for the Treatment of Alopecia Areata: A Review.
Dabek RJ; Roh DS; Ozdemir D; Austen WG; Bojovic B
Cureus; 2019 Jun; 11(6):e4943. PubMed ID: 31453018
[TBL] [Abstract][Full Text] [Related]
5. Combined microneedling with topical vitamin D3 or bimatoprost versus microneedling alone in the treatment of alopecia areata: A comparative randomized trial.
Ali MS; Hafiz HSA; Ahmed NA; Galal SA
J Cosmet Dermatol; 2023 Apr; 22(4):1286-1296. PubMed ID: 36762396
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of fractional carbon dioxide laser alone versus its combination with betamethasone valerate in treatment of alopecia areata, a clinical and dermoscopic study.
Halim DA; Nayer M; El-Samanoudy SI; Raheem HMA; Ragab N
Arch Dermatol Res; 2023 Apr; 315(3):505-511. PubMed ID: 36114868
[TBL] [Abstract][Full Text] [Related]
7. A review of monochromatic light devices for the treatment of alopecia areata.
Darwin E; Arora H; Hirt PA; Wikramanayake TC; Jimenez JJ
Lasers Med Sci; 2018 Feb; 33(2):435-444. PubMed ID: 29250710
[TBL] [Abstract][Full Text] [Related]
8. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil.
Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y
J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963
[TBL] [Abstract][Full Text] [Related]
9. Comparative study for treatment of alopecia areata using carboxy therapy, intralesional corticosteroids, and a combination of both.
Metwally D; Abdel-Fattah R; Hilal RF
Arch Dermatol Res; 2022 Mar; 314(2):167-182. PubMed ID: 33742252
[TBL] [Abstract][Full Text] [Related]
10. The role of fractional laser-assisted drug delivery in enhancing the efficacy of topical bimatoprost solution in the treatment of alopecia areata: An intra-patient comparative randomized clinical trial.
Meymandi SS; Safari A; Meymandi MS; Aflatoonian M
J Cosmet Dermatol; 2024 May; 23(5):1663-1668. PubMed ID: 38321929
[TBL] [Abstract][Full Text] [Related]
11. Comparative study between fractional carbon dioxide laser vs intralesional steroid injection in treatment of alopecia areata.
El-Husseiny R; Elframawy S; Abdallah M
Dermatol Ther; 2020 Jul; 33(4):e13742. PubMed ID: 32478930
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Conditioned Media From Human Adipocyte-Derived Mesenchymal Stem Cells on Androgenetic Alopecia After Nonablative Fractional Laser Treatment.
Lee YI; Kim J; Kim J; Park S; Lee JH
Dermatol Surg; 2020 Dec; 46(12):1698-1704. PubMed ID: 32769526
[TBL] [Abstract][Full Text] [Related]
13. Platelet-rich plasma in alopecia areata: intradermal injection versus topical application with transepidermal delivery via either fractional carbon dioxide laser or microneedling.
Ragab SEM; Nassar SO; Morad HA; Hegab DS
Acta Dermatovenerol Alp Pannonica Adriat; 2020 Dec; 29(4):169-173. PubMed ID: 33348935
[TBL] [Abstract][Full Text] [Related]
14. Microneedling combined with compound betamethasone in treatment of severe alopecia areata: A case report.
Pei D; Chen L; Yao Y; Zeng L; Zhang G
Front Immunol; 2022; 13():939077. PubMed ID: 35990624
[TBL] [Abstract][Full Text] [Related]
15. The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards the future.
Wipf A; Boysen N; Hordinsky MK; Dando EE; Sadick N; Farah RS
J Cosmet Laser Ther; 2019 Aug; 21(5):247-254. PubMed ID: 30300013
[No Abstract] [Full Text] [Related]
16. The role of laser and energy-assisted drug delivery in the treatment of alopecia.
Balazic E; Muskat A; Kost Y; Cohen JL; Kobets K
Lasers Med Sci; 2024 Feb; 39(1):73. PubMed ID: 38381230
[TBL] [Abstract][Full Text] [Related]
17. Intramuscular triamcinolone acetonide: An undervalued option for refractory alopecia areata.
Seo J; Lee YI; Hwang S; Zheng Z; Kim DY
J Dermatol; 2017 Feb; 44(2):173-179. PubMed ID: 27448451
[TBL] [Abstract][Full Text] [Related]
18. Treatment of alopecia areata with 2940-nm fractional erbium:yttrium-aluminum-garnet laser.
Tanakol A; Oba MC; Uzuncakmak TK; Askin O; Kutlubay Z
Dermatol Ther; 2020 Nov; 33(6):e13978. PubMed ID: 32633447
[TBL] [Abstract][Full Text] [Related]
19. Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study.
Meguid AMA; Ghazally A; Ahmed AM; Bakr RM
Arch Dermatol Res; 2023 Aug; 315(6):1675-1688. PubMed ID: 36809409
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
